文献速递免疫规划

粒细胞巨噬细胞集落刺激因子可改善多价疫苗中白喉成分的免疫应答

GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine.
PubMed 文献 · Vaccine · 2018-06-28

研究在小鼠中分析体内应用重组粒细胞巨噬细胞集落刺激因子(GM-CSF)对多价破伤风/白喉疫苗免疫效果的影响。GM-CSF可增强白喉特异性抗体产生和白喉特异性CD4+ T细胞,而不改变破伤风成分的体液和细胞免疫应答;在老年小鼠中也能增强白喉特异性免疫应答。

要点

  • GM-CSF增强多价破伤风/白喉疫苗诱导的白喉特异性抗体和CD4+ T细胞应答。
  • GM-CSF不改变对破伤风成分的体液和细胞免疫应答。
  • GM-CSF在老年小鼠中仍可增强白喉特异性免疫应答。

核心结论

  • 局部应用GM-CSF能够改善年轻和老年小鼠对多价破伤风/白喉疫苗中白喉成分的免疫应答。

研究设计与样本

  • 研究为小鼠实验,分析体内应用重组GM-CSF对多价破伤风/白喉疫苗免疫的影响,使用不同年龄的小鼠。

主要发现

  • 体内应用GM-CSF导致接种多价破伤风/白喉疫苗后白喉特异性抗体产生增强,白喉特异性CD4+ T细胞增多。
  • 对破伤风成分的体液和细胞免疫应答未改变。
  • 应用GM-CSF导致脾脏CD11b+树突状细胞(DCs)增多且MHC-II表达更高,并诱导更多CD11b+ DCs招募至注射肌肉。
  • GM-CSF能够增强老年小鼠对多价疫苗的白喉特异性免疫应答。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multivalent tetanus and diphtheria toxoid containing vaccines belong to the most frequently applied vaccines. However, there is an imbalance in the degree of protection against the two antigens with insufficient long-term protection against diphtheria, particularly in the elderly population. We have previously reported a positive correlation between granulocyte macrophage-colony stimulating factor (GM-CSF) and the production of diphtheria-specific antibodies. Therefore, in the present study we analyzed the effects of in vivo applied recombinant GM-CSF on immunization with multivalent tetanus/diphtheria vaccine in mice of different age. In vivo application of GM-CSF lead to enhanced production of diphtheria-specific antibodies as well as more diphtheria-specific CD4+ T cells following vaccination with multivalent tetanus/diphtheria vaccine. In contrast, the humoral and cellular immune response to the tetanus component was unaltered. Furthermore, application of GM-CSF resulted in more splenic CD11b+ dendritic cells (DCs) with a higher MHC-II expression. GM-CSF also induced a stronger recruitment of CD11b+ DCs to the injected muscle. Most remarkably, GM-CSF was able to boost the diphtheria-specific immune response to the multivalent vaccine in aged mice. This study demonstrates that local administration of GM-CSF is able to improve immune responsiveness to the diphtheria component of multivalent tetanus/diphtheria vaccine in young and old mice. This information could be useful for the future design of vaccines for the elderly.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Grasse M, Meryk A, Miggitsch C, et al. GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine. Vaccine. 2018. PMID: 29961602. doi:10.1016/j.vaccine.2018.06.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。